Nearly six months after it was declared, the Ebola outbreak in the Democratic Republic of the Congo (DRC) has spread to eight provinces in the east and northeast, infecting more than 10,500 people and killing about half of them.
The World Health Organization (WHO) is working with DRC authorities and other UN agencies on prevention, diagnosis, treatment and community awareness.
This week, two new vaccine candidates were approved for a clinical trial among contacts of patients with Ebola caused by the Bundibugyo species.
Dr. Meg Doherty, who heads WHO’s Science for Health Department, told UN News’s Daniel Johnson what the trial could mean for bringing the outbreak under control.
Source of original article: United Nations (news.un.org). Photo credit: UN. The content of this article does not necessarily reflect the views or opinion of Global Diaspora News (www.globaldiasporanews.com).
To submit your press release: (https://www.globaldiasporanews.com/pr).
To advertise on Global Diaspora News: (www.globaldiasporanews.com/ads).
Sign up to Global Diaspora News newsletter (https://www.globaldiasporanews.com/newsletter/) to start receiving updates and opportunities directly in your email inbox for free.
